Hematologic Malignancy
Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma
CI-CAN-00008565Explore in graph →
Hematologic1 active trials
- NCIt
- C157625
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008565Explore in graph →
Clinical trials
3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06247540 | Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | withdrawn | Phase 2 | 0 | Northwestern UniversityOTHER | 1 | Feb 29, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Feb 29, 2024source: clinicaltrials